Zavzpret (zavegepant nasal spray) — Cigna
Acute treatment of migraine with or without aura in adults
Initial criteria
- Patient age ≥ 18 years AND
- Patient has tried at least one triptan therapy OR has a contraindication to triptan(s) (e.g., coronary artery disease, cardiac accessory conduction pathway disorders, history of stroke, transient ischemic attack, hemiplegic or basilar migraine, peripheral vascular disease, ischemic bowel disease, uncontrolled hypertension, or severe hepatic impairment)
Approval duration
1 year